Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis

Documenti analoghi

• Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trial
  di: Xiaoling Li, et al.
  Pubblicazione: (2026)
• Long‐term survival after immunotherapy for uncontrolled locally advanced temporal bone squamous cell carcinoma followed by chemoradiotherapy: A case report
  di: Jin Yan, et al.
  Pubblicazione: (2024)
• Lymphocytopenia following adjuvant radiotherapy for breast cancer
  di: Kazuya Takeda, et al.
  Pubblicazione: (2024)
• Exploration of individualized neoadjuvant therapy model for operable esophageal cancer: A Surveillance, Epidemiology, and End Results database analysis
  di: Xingyu Zhou, et al.
  Pubblicazione: (2024)
• MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
  di: Shuang Chen, et al.
  Pubblicazione: (2026)